ICLR
Icon Plc (ICLR)
Healthcare • NASDAQ • $124.49-0.41%
- Symbol
- ICLR
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Price
- $124.49
- Daily Change
- -0.41%
- Market Cap
- $9.68B
- Trailing P/E
- 16.78
- Forward P/E
- 10.86
- 52W High
- $211.00
- 52W Low
- $66.57
- Analyst Target
- $137.21
- Dividend Yield
- N/A
- Beta
- 1.23
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition…
Company websiteResearch ICLR on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.